Torres-Lockhart KE - Search Results

1

Clinical Management of Opioid Withdrawal.

Torres-Lockhart KE, Lu TY, Weimer MB, Stein MR, Cunningham CO. Torres-Lockhart KE, et al. Addiction. 2022 Sep;117(9):2540-2550. doi: 10.1111/add.15818. Epub 2022 Feb 22. Addiction. 2022. PMID: 35112746 Review.

2

Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19.

Joseph G, Torres-Lockhart K, Stein MR, Mund PA, Nahvi S. Joseph G, et al. J Subst Abuse Treat. 2021 Mar;122:108219. doi: 10.1016/j.jsat.2020.108219. Epub 2020 Dec 3. J Subst Abuse Treat. 2021. PMID: 33353790 Free PMC article.

3

A comparison of office-based buprenorphine treatment outcomes in Bronx community clinics before versus during the COVID-19 pandemic.

Cunningham CO, Khalid L, Deng Y, Torres-Lockhart K, Masyukova M, Thomas S, Zhang C, Lu T. Cunningham CO, et al. J Subst Abuse Treat. 2022 Apr;135:108641. doi: 10.1016/j.jsat.2021.108641. Epub 2021 Oct 27. J Subst Abuse Treat. 2022. PMID: 34863608 Free PMC article.

4

Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines.

Calcaterra SL, Bottner R, Martin M, Englander H, Weinstein ZM, Weimer MB, Lambert E, Ronan MV, Huerta S, Zaman T, Ullal M, Peterkin AF, Torres-Lockhart K, Buresh M, O'Brien MT, Snyder H, Herzig SJ. Calcaterra SL, et al. J Hosp Med. 2022 Sep;17(9):679-692. doi: 10.1002/jhm.12908. Epub 2022 Jul 26. J Hosp Med. 2022. PMID: 35880821 Free PMC article.

5

Addiction Consult Service and Inpatient Outcomes Among Patients with Alcohol Use Disorder.

Singh-Tan S, Torres-Lockhart K, Jakubowski A, Lu T, Starrels J, De Lima P, Arnsten J, Nahvi S, Southern W. Singh-Tan S, et al. J Gen Intern Med. 2023 Nov;38(14):3216-3223. doi: 10.1007/s11606-023-08202-7. Epub 2023 Apr 26. J Gen Intern Med. 2023. PMID: 37100986 Free article.

6

Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation.

Jakubowski A, Singh-Tan S, Torres-Lockhart K, Nahvi S, Stein M, Fox AD, Lu T. Jakubowski A, et al. Addict Sci Clin Pract. 2023 May 18;18(1):31. doi: 10.1186/s13722-023-00386-x. Addict Sci Clin Pract. 2023. PMID: 37198707 Free PMC article.

7

Low-dose buprenorphine initiation and treatment continuation among hospitalized patients with opioid dependence: A retrospective cohort study.

Hayes BT, Li P, Nienaltow T, Torres-Lockhart K, Khalid L, Fox AD. Hayes BT, et al. J Subst Use Addict Treat. 2024 Mar;158:209261. doi: 10.1016/j.josat.2023.209261. Epub 2023 Dec 14. J Subst Use Addict Treat. 2024. PMID: 38103838

8

Mcl-1 and FBW7 control a dominant survival pathway underlying HDAC and Bcl-2 inhibitor synergy in squamous cell carcinoma.

He L, Torres-Lockhart K, Forster N, Ramakrishnan S, Greninger P, Garnett MJ, McDermott U, Rothenberg SM, Benes CH, Ellisen LW. He L, et al. Cancer Discov. 2013 Mar;3(3):324-37. doi: 10.1158/2159-8290.CD-12-0417. Epub 2012 Dec 28. Cancer Discov. 2013. PMID: 23274910 Free PMC article.

9

PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition.

Ibrahim YH, García-García C, Serra V, He L, Torres-Lockhart K, Prat A, Anton P, Cozar P, Guzmán M, Grueso J, Rodríguez O, Calvo MT, Aura C, Díez O, Rubio IT, Pérez J, Rodón J, Cortés J, Ellisen LW, Scaltriti M, Baselga J. Ibrahim YH, et al. Cancer Discov. 2012 Nov;2(11):1036-47. doi: 10.1158/2159-8290.CD-11-0348. Epub 2012 Aug 22. Cancer Discov. 2012. PMID: 22915752 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page